Royal London Asset Management LTD Boston Scientific Corp Transaction History

Royal London Asset Management LTD

  • $39.4 Billion
  • Q3 2024

A detailed history of Royal London Asset Management LTD transactions in Boston Scientific Corp stock. As of the latest transaction made, Royal London Asset Management LTD holds 635,079 shares of BSX stock, worth $65 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
635,079
Previous 612,554 3.68%
Holding current value
$65 Million
Previous $47.2 Million 12.82%
% of portfolio
0.13%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$72.96 - $84.0 $1.64 Million - $1.89 Million
22,525 Added 3.68%
635,079 $53.2 Million
Q2 2024

Aug 07, 2024
BUY
$67.33 - $77.71 $118,298 - $136,536
1,757 Added 0.29%
612,554 $47.2 Million
Q1 2024

May 14, 2024
BUY
$57.6 - $68.62 $902,016 - $1.07 Million
15,660 Added 2.63%
610,797 $41.8 Million
Q4 2023

Feb 13, 2024
BUY
$48.64 - $57.81 $1.08 Million - $1.28 Million
22,175 Added 3.87%
595,137 $34.4 Million
Q3 2023

Nov 14, 2023
BUY
$50.19 - $54.68 $1.66 Million - $1.81 Million
33,133 Added 6.14%
572,962 $30.3 Million
Q2 2023

Aug 11, 2023
BUY
$49.72 - $54.64 $1.63 Million - $1.79 Million
32,825 Added 6.47%
539,829 $29.2 Million
Q1 2023

May 15, 2023
SELL
$45.09 - $50.03 $201,777 - $223,884
-4,475 Reduced 0.87%
507,004 $25.4 Million
Q4 2022

Feb 09, 2023
BUY
$39.56 - $47.22 $208,204 - $248,518
5,263 Added 1.04%
511,479 $23.7 Million
Q3 2022

Nov 14, 2022
SELL
$36.71 - $109.66 $139,571 - $416,927
-3,802 Reduced 0.75%
506,216 $19.6 Million
Q2 2022

Aug 12, 2022
BUY
$35.24 - $47.1 $338,022 - $451,783
9,592 Added 1.92%
510,018 $19 Million
Q1 2022

May 13, 2022
BUY
$40.9 - $45.1 $1.28 Million - $1.42 Million
31,391 Added 6.69%
500,426 $22.2 Million
Q4 2021

Oct 18, 2022
SELL
$38.07 - $44.87 $1.12 Million - $1.32 Million
-29,482 Reduced 5.91%
469,035 $19.9 Million
Q4 2021

Jan 18, 2022
SELL
$38.07 - $44.87 $1.12 Million - $1.32 Million
-29,482 Reduced 5.91%
469,035 $19.9 Million
Q3 2021

Oct 18, 2022
SELL
$41.23 - $45.88 $1.49 Million - $1.66 Million
-36,218 Reduced 6.77%
498,517 $21.6 Million
Q3 2021

Nov 02, 2021
SELL
$41.23 - $45.88 $1.49 Million - $1.66 Million
-36,218 Reduced 6.77%
498,517 $21.6 Million
Q2 2021

Oct 18, 2022
BUY
$38.58 - $44.24 $953,581 - $1.09 Million
24,717 Added 4.85%
534,735 $22.9 Million
Q1 2021

Oct 17, 2022
BUY
$35.27 - $39.67 $871,768 - $980,523
24,717 Added 4.85%
534,735 $20.7 Million
Q1 2021

Apr 13, 2021
BUY
$35.27 - $39.67 $561,568 - $631,625
15,922 Added 3.07%
534,735 $20.7 Million
Q4 2020

Jan 29, 2021
SELL
$33.15 - $41.97 $191,474 - $242,418
-5,776 Reduced 1.1%
518,813 $18.6 Million
Q3 2020

Nov 04, 2020
SELL
$34.44 - $42.23 $76,181 - $93,412
-2,212 Reduced 0.42%
524,589 $19.8 Million
Q2 2020

Jul 31, 2020
SELL
$30.19 - $39.11 $445,544 - $577,185
-14,758 Reduced 2.73%
526,801 $18.3 Million
Q1 2020

May 01, 2020
SELL
$25.83 - $45.71 $270,775 - $479,177
-10,483 Reduced 1.9%
541,559 $17.1 Million
Q4 2019

Feb 05, 2020
BUY
$37.87 - $45.37 $327,651 - $392,541
8,652 Added 1.59%
552,042 $24.8 Million
Q3 2019

Nov 12, 2019
BUY
$40.31 - $43.45 $566,073 - $610,168
14,043 Added 2.65%
543,390 $22.1 Million
Q2 2019

Jul 31, 2019
SELL
$34.91 - $42.98 $1.19 Million - $1.46 Million
-34,079 Reduced 6.05%
529,347 $22.7 Million
Q1 2019

Apr 30, 2019
SELL
$32.91 - $40.75 $948,630 - $1.17 Million
-28,825 Reduced 4.87%
563,426 $0
Q4 2018

Jan 29, 2019
BUY
$31.73 - $39.04 $18.8 Million - $23.1 Million
592,251 New
592,251 $20.5 Million
Q3 2018

Nov 08, 2018
SELL
$32.83 - $38.63 $18.9 Million - $22.2 Million
-575,800 Closed
0 $0
Q2 2018

Sep 19, 2018
BUY
$26.84 - $34.32 $15.5 Million - $19.8 Million
575,800 New
575,800 $18.8 Million

Others Institutions Holding BSX

# of Institutions
1,574
Shares Held
1.18B
Call Options Held
6.82M
Put Options Held
10.1M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $146B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Royal London Asset Management LTD Portfolio

Follow Royal London Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email